Artivion (AORT) Income from Non-Controlling Interests (2011 - 2015)
Artivion (AORT) posted Income from Non-Controlling Interests of $342000.0 for Q2 2015, up 392.31% on a QoQ basis from -$117000.0 in Q1 2015, and up 734.15% year-over-year from $41000.0 in Q2 2014.
Artivion (AORT) Income from Non-Controlling Interests (2011 - 2015) Analysis & Trends
Artivion's Income from Non-Controlling Interests history runs 5 years deep, the most recent figure standing at $342000.0 for Q2 2015.
- Quarterly Income from Non-Controlling Interests rose 734.15% year-over-year to $342000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $186000.0 (up 500.0% YoY) and the FY2013 annual result came in at $46000.0, up 239.39% from the prior year.
- Income from Non-Controlling Interests was $342000.0 for Q2 2015 at Artivion, up from -$117000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $342000.0 in Q2 2015 and bottomed at -$117000.0 in Q1 2015.
- A 5-year average of $11176.5 and a median of $6000.0 in 2012 frame the typical range for Income from Non-Controlling Interests.
- Peak annual rise in Income from Non-Controlling Interests reached 800.0% in 2013, while the deepest fall reached 1750.0% in 2013.
- Artivion's Income from Non-Controlling Interests stood at $21000.0 in 2011, then slumped by 390.48% to -$61000.0 in 2012, then surged by 113.11% to $8000.0 in 2013, then slumped by 1100.0% to -$80000.0 in 2014, then soared by 527.5% to $342000.0 in 2015.
- Business Quant data shows AORT's Income from Non-Controlling Interests at $342000.0 in Q2 2015, -$117000.0 in Q1 2015, and -$80000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -5.85 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 342,000.00 |
| Mar 31, 2015 | -117,000.00 |
| Sep 30, 2014 | -80,000.00 |
| Jun 30, 2014 | 41,000.00 |
| Mar 31, 2014 | -35,000.00 |
| Dec 31, 2013 | 8,000.00 |
| Sep 30, 2013 | 17,000.00 |
| Jun 30, 2013 | 54,000.00 |
| Mar 31, 2013 | -33,000.00 |
| Dec 31, 2012 | -61,000.00 |
| Sep 30, 2012 | 20,000.00 |
| Jun 30, 2012 | 6,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | 21,000.00 |
| Sep 30, 2011 | -5,000.00 |
| Jun 30, 2011 | -6,000.00 |
| Mar 31, 2011 | 16,000.00 |